Skip to content

Peripartum Cesarean Hysterectomy for Placenta Percreta

Peripartum Cesarean Hysterectomy for Placenta Percreta: a Retrospective Analysis of Cases With and Without Extrauterine Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05979181
Enrollment
73
Registered
2023-08-07
Start date
2018-10-20
Completion date
2023-02-17
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Accreta

Keywords

PAS, Placenta previa, Placenta accreta, Cesarean hysterectomy

Brief summary

The aim of this study is to address the possible preoperative determinants of extrauterine diseases in cases of placenta previa percreta and to compare the operative and postoperative characteristics of cases with and without extrauterine disease.

Detailed description

This will be a retrospective study of the data of women who underwent cesarean hysterectomy on placenta previa percreta who were classified as Federation of Gynecology and Obstetrics (FIGO) grade 3. Women without extrauterine disease (FIGO grade 3a) will be compared to women with extrauterine disease (FIGO grades 3b and 3c)

Interventions

Cesarean hysterectomy due to placenta previa percreta with no extrauterine disease (FIGO grade 3a) or with extrauterine disease (FIGO grades 3b and 3c)

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Women who underwent cesarean hysterectomy on placenta previa percreta (FIGO grade 3).

Exclusion criteria

* Medical conditions complicating pregnancy. * Blood diseases or bleeding tendencies

Design outcomes

Primary

MeasureTime frameDescription
Estimated amount of intraoperative blood lossFrom start to end of operationCalculated amount of blood loss during the operation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026